Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Toxicology|January 6, 1995
CYP1 induction, binding to the hepatic aromatic hydrocarbon receptor and mutagenicity of a series of 11-alkoxy cyclopenta[a]phenanthren-17-ones: a structure activity relationshipG W Boyd, M M Coombs, C IoannidesToxicology Letters|January 1, 1995
The influence of dihydrodiol conformation on the metabolic activation of cyclopenta[a]phenanthrenesG W Boyd, C Ioannides, M M CoombsCancer Research|December 1, 1976
An investigation into the binding of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to DNA in vitroM M Coombs, A M Kissonerghis, J A AllenCarcinogenesis|January 1, 1982
Carcinogenicity and mutagenicity of some alkoxy cyclopenta[a]phenanthren-17-ones; effect of obstructing the bay regionT S Bhatt, S T Hadfield, M M CoombsCancer Research|February 1, 1975
The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitorM M Coombs, T S Bhatt, C W VoseMutation Research|December 24, 1997
Bioactivation of mushroom hydrazines to mutagenic products by mammalian and fungal enzymesK Walton, M M Coombs, R Walker, et al.Carcinogenesis|October 1, 1995
The presence of a trifluoromethyl rather than a methyl substituent in the bay-region greatly decreases the DNA-binding and tumour-initiating activity of the cyclopenta[alpha]phenanthren-17-onesG W Boyd, M M Coombs, W M BairdToxicology|April 12, 2001
The metabolism and bioactivation of agaritine and of other mushroom hydrazines by whole mushroom homogenate and by mushroom tyrosinaseK Walton, M M Coombs, R Walker, et al.Carcinogenesis|November 1, 1984
The biological activity and activation of 15,16-dihydro-1,11-methanocyclopenta[a]phenanthren-17-one, a carcinogen with an obstructed bay regionS T Hadfield, T S Bhatt, M M CoombsPageof 5